The global atipamezole market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Atipamezoles is a synthetic ?? adrenergic receptor antagonist. It is an anti-sedative drug that is indicated for the reversal of the sedative and analgesic effects of dexmedetomidine and medetomidine in dogs. The major factor for the growth of the market is the rising adoption of pets. According to the APPA National Pet Owners Survey 2021-2022, 70% of the US households own a pet, which equates to 90.5 million homes. Additionally, in 2019-2020, 63.4 million households had at least one dog and 42.7 million households had at least one cat. Hence, the rising adoption of pets is driving the demand for atipamezole that is used for the treatment of amitraz and imidazoline decongestants toxicity in animals. According to the American Pet Products Association (APPA), in 2020, a total of $103.6 billion was spent on pets, out of which vet care and product sales accounted for $31.4 billion. This rising awareness regarding pet health is attributing to the growth of the global atipamezole market.
To Request a Sample of our Report on Atipamezole Market: https://www.omrglobal.com/request-sample/atipamezole-market
Some major players in the market include Zoetis Inc., Merck KGaA, Pfizer Inc., and Vetoquinol SA, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in January 2021, Dechra launched ATIPAM. It is an injectable 5 mg/mL Atipamezole Hydrochloride solution that is indicated for the reversal of the clinical effects of dexmedetomidine hydrochloride and medetomidine hydrochloride in dogs.
Market Coverage
• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered-
· By Application
· By Route of Administration
· By Animal Type
• Regions Covered-
· North America
· Europe
· Asia-Pacific
· Rest of the World
• Competitive Landscape-Zoetis Inc., Merck KGaA, Pfizer Inc., and Vetoquinol SA, among others.
(Get 15% Discount on Buying this Report)
A full Report of Atipamezole Market is Available @: https://www.omrglobal.com/industry-reports/atipamezole-market
Global Atipamezole Market Report by Segment
By Application
• Anti-Sedative
• Anti-Toxic (Off-Label Use)
By Route of Administration
• Intravenous
• Intramuscular
• Others
By Animal Type
• Dogs
• Cats
• Others
Global Atipamezole Market Report by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
· Latin America
· Middle East & Africa
Reasons to buy from us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
